Abstract
Inflammation is a programmed response to tissue injury and microbial agents. In primitive multicellular organisms, humoral and cellular constituents of host defenses are focused by the presence of a foreign body or at a site of tissue injury. The evolution in higher organisms of a discrete circulatory system introduced complexity that imposed a need for mechanisms regulating changes in permeability of the circulatory system and for margination/directed migration of circulating cellular elements. For instance, an array of regulated genes expressed in endothelium, blood leukocytes, and in extra- vascular cells direct the accumulation of white cells to sites of inflammation. Proteins within the selectin family (McEver 1991) displayed on the majority of lymphocytes, neutrophils, monocytes, and the corresponding cytokine- regulated proteins on endothelium, are critical for the recruitment of white cells to an inflammatory site. Similar general functions are served by adhesion molecules of the integrin and immunoglobulin (Ig) families (Springer 1990; Kishimoto et al. 1989).Small molecular species such as nitric oxide (Kubes et al. 1991), arachadonic acid metabolites (Smith et al. 1980), and reactive oxygen radicals (Patel 1991) generated at inflammatory sites, play modulating and direct roles in leukocyte adherence, migration, activation. This process involves elaborate control mechanisms and is highly redundant even when considering only the intravascular elements. In addition, separate vascular and peripheral tissue sources of the critical constituents evolved. This has resulted in separate regulatory mechanisms that govern availability of the intravascular and extravascular components of the inflammatory response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alper CA, Raum D, Awdeh Z, et al (1980) Studies of hepatic synthesis in vivo of plasma proteins including orosomucoid, transferrin, alpha-1-antitrypsin, C8 and factor B. Clin Immunol Immunopathol 16:84–89
Ahrenstedt O, Knutson L, Nilsson B, et al (1990) Enhanced local production of complement components in the small intestines of patients with Crohn’s disease. N Engl J Med 322:1345–1349
Alper CA, Rosen FS (1967) Studies of the in vivo behavior of human C3 in normal subjects and patients. J Clin Invest 46:2021
Atkinson JP, Farries TJ (1987) Separation of self from non-self in the complement system. Immunol Today 8:212–215
Ault BH, Colten HR (1994) Cellular specificity of murine renal C3 expression in two models of inflammation. Immunology 81:655–660
Bartholomew RM, Esser AF (1980) mechanism of antibody-independent activation of the first component of complement (CI) on retrovirus membranes. Biochemistry 19:2847–2853
Ben-Efraim S, Cinader B (1964) The role of complement in the passive cutaneous reactions of mice. J Exp Med 120:925–942
Bozic CR, Lu B, Hopken UE, Gerard C, Gerard NP (1996) Neurogenic amplification of immune complex inflammation. Science 273:1722–1725
Botto M, DelPAgnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous Clq deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56–59
Brooimans RA, Stegman APA, Daha MR, van der Ark AAJ, van der Woude JF, van Es LA, van Dorp WT (1991) Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 88:379
Burger R, et al (1986) An inherited deficiency of the 3rd component of complement
C3, in guinea pigs. Eur J Immun 16:7–11
Colten HR (1994) News and Views:Drawing a double-edged sword. Nature 371:474–475
Cooper NR, Jensen FC, Welsh RM, Oldstone MBA (1976). Lysis of RNA tumor viruses by human serum:direct antibody-independent triggering of the classical complement pathway. J Exp Med 144:970–984
Cooper NR, Nemerow GR (1983) Complement, viruses, and virus-infected cells. Springer Semin Immunopathol 6:327–347
Croix DA, Ahearn JM, Carroll MC, Han S, Kelsoe G, Ma M, Rosengard AM (1996) Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med 183:1857–1864
Dunckley H, Gatenby PA, Hawkins B, Naito S, Serjeantson SW (1987) Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J Immunogenet 14:209–218
Einstein LP, Alper CA, Bloch KH, et al (1975) A biosynthetic defect in monocytes from humans with genetic deficiency of the second component of complement (C2). N Engl J Med 292:1169–1171
Falus A, Beuscher HU, Auerbach HS, Colten HR (1987) Constitutive and IL-1-regulated murine complement gene expression is strain and tissue specific. J Immunol 138:856
Fearon DT, Austen KF, Ruddy S (1973) Formation of a hemolytically active cellular intermediate by the interaction between proper din factors B and D and the activated third component of complement. J Exp Med 138:1305–1313
Fiedler AHL, Walport MJ, Batchelor JR, et al (1983) Family study of the MHC in patients with SLE:Importance of null alleles of C4A and C4B in determining disease susceptibility. Brit Med J 286:425–428
Fischer MB, Ma M, Carroll MC, Finco O, Goerg S, Han S, Howard RG, Kelsoe G, Kremmer E, Rosen FS, Rothstein TL, Xia J, Zhou X (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. Immunol 157:549–556
Frank MM, Fries LF (1991) The role of complement in inflammation and phagocytosis. Immunol Today 12:322–326
Friend P, Repine J, Clawson CC, Kim Y, Michael AF (1975) Deficiency of the second component of complement (C2) with chronic vasculitis. Ann Int Med 83:813–816
Gelfand EW, Clarkson JO, Minta JO (1975) Selective deficiency of the second component of complement in a patient with anaphylactoid purpura. Clin Immunol Immunopathol 4:269–276
Hauptmann G, Tappeiner G, Schifferli JA (1988) Inherited deficiency of the fourth component of human complement. Immunodef Rev 1:3–22
Hazenbos WLW, Gessner JE, Capel PJA, Daeron M, Heijnen IAFM, Hofhuis FMA, Kuipers H, Meyer D, Sandor M, Schmidt RE, Van de Winkel JGJ, Verbeek JS (1996) Impaired IgG dependent anaphylaxis and Arthus reaction in FcGamma Rill (CD16) deficient mice. Immunity 5:181–188
Hopken UE, Lu B, Gerard C, Gerard NP (1996) The C5a chemoattractant receptor mediates mucosal defense to infection. Nature 383:86–89
Hourcade D, Holers VM, Atkinson JP (1989) The regulators of complement activation (RCA) gene cluster. Adv Immunol 45:381–416
Hugli TE (1986) Biochemistry and biology of anaphylatoxins. Complement 3:111–127
Kaplan MH, Volanakis JE (1974) Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with choline phosphatides, lecithin and sphingomyelin. J Immunol 112:2135–2147
Katz Y, Cole FS, Strunk RC (1988) Synergism between interferon-gamma and lipo- polysaccharide for synthesis of factor B, but not C2, in human fibroblasts. J Exp Med 167:1–14
Kim Y, Friend PS, Dresner IG, Michael AF, Yunis EJ (1977) Inherited deficiency of the second component of complement (C2) deficiency with membranoproliferative glomerulonephritis. Am J Med 62:765–771
Kinoshita T, Medof ME, Silber R, Nussenzweig V (1985) Distribution of decay-accel- erating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 162:75–92
Kishimoto TK, Larson RS, Carabi AL, Dustin ML, et al (1989) The leukocyte inte-grins. In:Dixon FJ (ed) New York:Academic Press 46:149–182
Kubes P, Suzuki M, Granger DN (1991) Nitric oxide:an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sei USA 88:4651–4655
Kushner I (1982) The phenomenon of the acute phase response. Ann NY Acad Sei 389:39–48
Leddy JP, Griggs RC, Frank MM, Klemperer MR (1975) Hereditary complement C3 deficient with dermatomyositis. Am J Med 58:83–91
Liszewski MJ, Tedja I, Atkinson JP (1994) Membrane cofactor protein (CD46) of complement. J Biol Chem 269:10776–10779
Lublin DM, Atkinson JP (1989) Decay-accelerating factor:Biochemistry, molecular biology, and function. Ann Rev Immunol 7:35–58
Mathew M, Bolten WK (1988) Linear C3 deposits on the tubular basement membrane in renal allograft biopsies. Amer J Kidney Dis 12:121
McEver RP (1991) Leukocyte interactions mediated by selectins. Thromb Haemost 66:80–87
Muller-Eberhard HJ (1975) Complement. Annu Rev Biochem 44:697–724
Muller-Eberhard HJ (1986) The membrane attack complex of complement. Ann Rev Immunol 4:503–528
Muller-Eberhard HJ (1988) Molecular organization and function of the complement system. Annu Rev Biochem 57:321–347
Naughton MA, Botto M, Carter MJ, Alexander GM, Goldman JM, Walport MJ (1996) Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J Immunol 156:351
Naughton MA, Walport JM, Wurzner R, Carter MJ, Alexander GJM, Goldman JM, Botto M (1996) Organ-specific contribution to circulating C7 levels by the bone marrow and liver in humans. Eur J Immunol 26:2108–2112
Passwell J, Schreiner GF, Nonaka M, (1988) Local extrahepatic expression of complement genes C3, factor B, C2 and C4 is increased in murine lupus nephritis. J Clin Invest. 82:1676–
Passwell JH, Schreiner GF, Wetsel RA, Colten HR (1990) Complement gene expression in hepatic and extrahepatic tissues of NZB and NZBxW (Fl) mouse strains. Immunology 71:290–294
Pangburn MK, Muller-Eberhard HJ (1984) The alternative pathway of complement. Springer Semin Immunopathol 7:163–192
Patel KD, Zimmerman GA, Prescott SM, et al (1991) Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 112:749–759
Perlmutter DH, Colten HR (1992) Complement:molecular genetics. Inflammation, 2nd edn, 81
Peters DK, Martin A, Weinstein A, et al (1972) Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol 11:311
Podack ER, Muller-Eberhard HJ (1985) Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. J Biol Chem 254:9908–9914
Richards RL, Gewürz H, Alving CR, Osmand AP (1977) Interactions of C-reactive protein and complement with liposomes. Proc Natl Acad Sei USA 74:5672–5676
Rudofsky UH, Pollara B (1981) Experimental autoimmune renal tubulointerstitial disease. In:Cummings NB, Michael AF, Silson CB (eds) Immune mechanisms in renal disease. Plenum Medical Book Company, NY, p 261
Salvesen GS, Catanese JJ, Kress LF, Travis J (1985) Primary structure of the reactive site of human CI inhibitor. J Biol Chem 260:2432–2436
Schifferli JA, Woo P, Peters DK (1982) Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. Clin Exp Immunol 47:555–562
Smith MJH, Ford-Hutchinson AW, Bray MA (1980) Leukotriene B:a potential mediator of inflammation. J Pharm Pharmacol 32:517–518
Springer TA (1990) Adhesion receptors of the immune system. Nature 346:425–434
Storrs SB, Kolb WP, Pinckard RN, Olson MS (1981) Characterization of the binding of purified human Clq to mitochondrial membranes. J Biol Chem 256:10924–10929
Striker LJ, Olson JM, Striker GF (1990) The Renal Biopsy. W.B. Saunders Company, Philadelphia
Sylvestre DL, Ravetch JV (1994) Fc receptors initiate the Arthus reaction:redefining the inflammatory cascade. Science 265:1095–1098
Sylvestre DL, Ravetch JV (1996) A dominant role for mast cell Fc receptors in the
Arthus reaction. Immunity 5:387–390
Takai T, Li M, Clynes R, Ravetch JV, Sylvestre D (1994) FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76:519–529
Tillett WS, Francis T Jr (1930) Serological reactions in pneumonia with non-protein sumatic fraction of Pneumococcus. J Exp Med 52:561–571
Vogt W, Dames W, Schmidt G, Dieminger L (1997) Complement activation by the properdin system:formation of a stoichiometric C3 cleaving complex of properdin factor B with C3b. Immunochemistry 14:201–205
Weiser MR, Williams JP, Hechtman HB, Carroll MC, Kobzik L, Ma M, Moore FD Jr (1996) Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183:2343–2348
Welsh RM, Cooper NR, Jensen FC, Oldstone MBA (1975) Human serum lyses RNA tumor viruses. Nature 257:612–614
Welch TR, Witte DP, Beischel LS (1991) Differential expression and cellular localization of messenger RNA for C3 and C4 in the human kidney. Complement Inflamm 8:141
Welch TR, Witte DP, Beischel LS (1991) Differential expression and cellular localization of messenger RNA for C3 and C4 in the human kidney. Complement Inflamm 8:241
Wilson WA, Perez MC (1988) Complete CC4B deficiency in black Americans with systemic lupus erythematosus. J Rheumatol 15:1855–1858
Winkelstein JA, Sullivan KE, Colten HR (1995) Genetically determined disorders of the complement system. In: Scriver CR, Beaudet AL, Sly WS, Alle D (eds) The metabolic and molecular bases of inherited disease, 7th ed. McGraw-Hill, New York, pp 3911–3941
Zipfel PF, Skerka C (1994) Complement factor H and related proteins: an expanding family of complement-regulatory proteins? Immunol Today 15:121–126
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Colten, H.R. (1999). Complement and Inflammation. In: Eibl, M.M., Huber, C., Peter, H.H., Wahn, U. (eds) Symposium in Immunology VIII. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59947-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-59947-7_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-64722-5
Online ISBN: 978-3-642-59947-7
eBook Packages: Springer Book Archive